Literature DB >> 19180096

2008 FDA drug approvals.

Bethan Hughes.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19180096     DOI： 10.1038/nrd2813

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  2007 FDA drug approvals: a year of flux.

Authors:  Bethan Hughes
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

2.  Anticipating REMS.

Authors: 
Journal:  Nat Rev Drug Discov       Date:  2008-12       Impact factor: 84.694
  2 in total
  11 in total

1.  Drug discovery in a multidimensional world: systems, patterns, and networks.

Authors:  Joel T Dudley; Eric Schadt; Marina Sirota; Atul J Butte; Euan Ashley
Journal:  J Cardiovasc Transl Res       Date:  2010-07-31       Impact factor: 4.132

Review 2.  Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery.

Authors:  Ali Nsair; W Robb MacLellan
Journal:  Adv Drug Deliv Rev       Date:  2011-03-01       Impact factor: 15.470

Review 3.  Roadmap to risk evaluation and mitigation strategies (REMS) success.

Authors:  John D Balian; Janice C Wherry; Rachpal Malhotra; Valerie Perentesis
Journal:  Ther Adv Drug Saf       Date:  2010-10

4.  Dose effects of lacosamide as add-on therapy for partial-onset seizure in adult.

Authors:  Deng Chen; Yan Lin; Tao Chen; Qin Zhang; Yan Lin; Yang Si; Wen-Wu Zhang; Da Xu; Ling Liu
Journal:  Neurol Sci       Date:  2016-02-20       Impact factor: 3.307

5.  Forecasting drug utilization and expenditure in a metropolitan health region.

Authors:  Björn Wettermark; Marie E Persson; Nils Wilking; Mats Kalin; Seher Korkmaz; Paul Hjemdahl; Brian Godman; Max Petzold; Lars L Gustafsson
Journal:  BMC Health Serv Res       Date:  2010-05-17       Impact factor: 2.655

6.  Unraveling the autoimmune translational research process layer by layer.

Authors:  Richard S Blumberg; Bonnie Dittel; David Hafler; Matthias von Herrath; Frank O Nestle
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

7.  The clinical pharmacogeneticist: an emerging regulatory scientist at the US Food and Drug Administration.

Authors:  Issam Zineh; Janet Woodcock
Journal:  Hum Genomics       Date:  2010-04       Impact factor: 4.639

Review 8.  Rapid analysis of pharmacology for infectious diseases.

Authors:  Andrew L Hopkins; G Richard Bickerton; Ian M Carruthers; Stephen K Boyer; Harvey Rubin; John P Overington
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

Review 9.  Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives.

Authors:  Jessica Marinello; Maria Delcuratolo; Giovanni Capranico
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

10.  How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.

Authors:  Paul G Germann; Alexander Schuhmacher; Juan Harrison; Ronald Law; Kevin Haug; Gordon Wong
Journal:  Hum Genomics       Date:  2013-03-05       Impact factor: 4.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.